Your browser doesn't support javascript.
loading
Rapidly progressing primary splenic angiosarcoma with fatal hemorrhagic event.
J Chemother ; 26(4): 248-52, 2014 Aug.
Article in En | MEDLINE | ID: mdl-24139479
Primary angiosarcoma of the spleen is an extremely rare malignancy. Splenic angiosarcoma is difficult to diagnose, and treatment is often challenging. The prognosis is dismal, with a mean survival of less than 1 year. Currently, no standard treatment methods have been established. Anecdotal reports suggest that early diagnosis and prompt splenectomy followed by cytotoxic chemotherapy can be effective treatment modalities. We report a case of rapidly progressing primary splenic angiosarcoma with multiple liver and bone metastases and a fatal hemorrhagic outcome.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Splenic Neoplasms / Bone Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Hemangiosarcoma / Liver Neoplasms Type of study: Diagnostic_studies / Prognostic_studies / Screening_studies Limits: Adult / Humans / Male Language: En Journal: J Chemother Journal subject: ANTINEOPLASICOS / TERAPIA POR MEDICAMENTOS Year: 2014 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Splenic Neoplasms / Bone Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Hemangiosarcoma / Liver Neoplasms Type of study: Diagnostic_studies / Prognostic_studies / Screening_studies Limits: Adult / Humans / Male Language: En Journal: J Chemother Journal subject: ANTINEOPLASICOS / TERAPIA POR MEDICAMENTOS Year: 2014 Document type: Article Country of publication: United kingdom